Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of innovative therapeutics, presented new preclinical data ...

Portage Biotech have more than doubled in the after-hours market after the company reported preclinical results for PORT-7 in a murine mesothelioma model. In the Thursday late trading session, the ...

Investing.com -- Shares of Portage Biotech Inc. (NASDAQ: PRTG) surged 29% following the presentation of new preclinical data for its mesothelioma treatment, PORT-7. The company unveiled these findings ...

Combining PORT-6 and PORT-7 for a More Comprehensive Immunotherapy Approach ...

Biliary Tract Cancer (BTC): KEYTRUDA may be combined with chemotherapy medicines to treat BTC, a cancer that affects the bile ducts or gallbladder. This treatment is for adults when the cancer has ...

Hedy Lee Kindler, MD, shares new mesothelioma guidelines that have been released by the American Society of Clinical Oncology ...

A mesothelioma lawyer is more than just a legal representative; they become your partner in this fight. They’re there to help you navigate the complexities, secure your financial future, and get the ...

Latigo Biotherapeutics, Vivace Therapeutics, and Vori Health each announced the recent successful closing of their respective ...

Asbestos is still claiming the lives of many of our veterans nationwide. But there is help now from the Veterans ...

After being used since the 1940s in various industries, asbestos is now linked to severe health risks, including asbestosis, ...

Montana has a rich history of asbestos mining and use. In this state, the Environmental Protection Agency declared for the ...

In 1922, the U.S. Navy identified the naturally occurring asbestos mineral as the most efficient and cost-effective ...